
This phase I study investigated the maximum tolerated dose and zzso of a zzso administration of zzso a zzso zzso at three dose levels zzso zzso 110 and 150 zzso zzso zzso combined with zzso zzso dose 75 zzso zzso In 16 patients with advanced zzso treated, one patient experienced zzso zzso zzso zzso and severe colitis at the 150 zzso zzso zzso at the 110 zzso zzso DL one episode of zzso grade 3 zzso zzso Grade 3/4 zzso zzso were zzso grade 3 zzso zzso were zzso zzso zzso and zzso zzso response was seen in four patients, with three complete zzso in zzso and cervical cancer zzso zzso of zzso appeared linear through the 110 zzso zzso but not through the 150 zzso zzso zzso The zzso values for zzso distribution volume at steady state and terminal zzso during cycle 1 were zzso zzso zzso zzso zzso zzso zzso and zzso zzso zzso The maximum tolerated and recommended phase II dose for zzso was 110 zzso zzso zzso infusion, every 3 weeks) combined with zzso 75 zzso zzso 

